首页>外文期刊>医学、药学、卫生>肿瘤学>Liver cancer.

Liver cancer.

SCIMEDLINE

中文名称：肝癌。

ISSN：2235-1795
出版周期：Quarterly

发文量：25

期刊论文

热门论文

年度选择

2019
- 第1期
- 第2期
- 第3期
- 第4期
- 第5期
- 第6期
2018
- 第1期
- 第2期
- 第3期
- 第4期
2017
- 第1期
- 第2期
- 第3期
- 第4期
2016
- 第1期
- 第2期
- 第3期
- 第4期
2015
- 第1期
- 第2期
- 第3期
- 第4期
2014
- 第1期
- 第2期
- 第4期

更多>>

全选（0）

1.Long-Term Prognostic Factors after Hepatic Resection for Hepatitis C Virus-Related Hepatocellular Carcinoma, with a Special Reference to Viral Status

机译：肝切除后的长期预后因素对丙型肝炎病毒相关肝细胞癌，特别是病毒状态
- 作者：Koda Masaki;Tanaka Shogo;Takemura Shigekazu;Shinkawa Hiroji;Kinoshita Masahiko;Hamano Genya;Ito Tokuji;Kawada Norifumi;Shibata Toshihiko;Kubo Shoji
- 期刊名称：《Liver cancer.》 | 2018年第3期
- Hepatocellular carcinoma;
- Hepatitis C;
- Interferon;
- Surgery;
- Sustained virological response;
2.Extremely High Objective Response Rate of Lenvatinib: Its Clinical Relevance and Changing the Treatment Paradigm in Hepatocellular Carcinoma

机译：Lenvatinib的极高目标反应率：其临床相关性和改变肝细胞癌的治疗范式
- 作者：Kudo Masatoshi
- 期刊名称：《Liver cancer.》 | 2018年第3期
3.Proposal of Primary Endpoints for TACE Combination Trials with Systemic Therapy: Lessons Learned from 5 Negative Trials and the Positive TACTICS Trial

机译：具有全身疗法的TACE组合试验的主要终点提出：从5个负面试验和积极的策略试验中汲取的经验教训
- 作者：Kudo Masatoshi
- 期刊名称：《Liver cancer.》 | 2018年第3期
4.Characterization of Hepatocellular Carcinoma Patients with FGF19 Amplification Assessed by Fluorescence in situ Hybridization: A Large Cohort Study

机译：荧光杂交评估FGF19扩增患者肝细胞癌患者的表征：大队列研究
- 作者：Hyo?Jeong Kang;Farhan Haq;Chang?Ohk Sung;Jene Choi;Seung-Mo Hong;Soo-Heang Eo;Hui?Jeong Jeong;Jinho Shin;Ju?Hyun Shim;Han?Chu Lee;Jihyun An;Mi-Ju Kim;Kyu-pyo Kim;Sung-Min Ahn;Eunsil Yu
- 期刊名称：《Liver cancer.》 | 2019年第1期
- FGF19;
- Fluorescence in situ hybridization;
- Hepatocellular carcinoma;
- High copy number amplification;
- Prognosis;
5.Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma

机译：差分器官特异性肿瘤对肝细胞癌免疫检查点抑制剂的反应
- 作者：Lu Li-Chun;Hsu Chiun;Shao Yu-Yun;Chao Yee;Yen Chia-Jui;Shih I-Lun;Hung Yi-Ping;Chang Chun-Jung;Shen Ying-Chun;Guo Jhe-Cyuan;Liu Tsung-Hao;Hsu Chih-Hung;Cheng Ann-Lii
- 期刊名称：《Liver cancer.》 | 2019年第6期
- Hepatocellular carcinoma;
- Immune checkpoint inhibitor;
- Tumor microenvironment;
- Tumor response;
- Immune contexture;
6.Objective Response by mRECIST Is an Independent Prognostic Factor for Overall Survival in Hepatocellular Carcinoma Treated with Sorafenib in the SILIUS Trial

机译：MRecist的客观反应是Silius试验中Sorafenib治疗的肝细胞癌整体存活的独立预后因素
- 作者：Kudo Masatoshi;Ueshima Kazuomi;Chiba Yasutaka;Ogasawara Sadahisa;Obi Shuntaro;Izumi Namiki;Aikata Hiroshi;Nagano Hiroaki;Hatano Etsuro;Sasaki Yutaka;Hino Keisuke;Kumada Takashi;Yamamoto Kazuhide;Imai Yasuharu;Iwadou Shouta;Ogawa Chikara;Okusaka Takuji;Kanai Fumihiko;Arai Yasuaki
- 期刊名称：《Liver cancer.》 | 2019年第6期
- Hepatocellular carcinoma;
- Objective response;
- Modified RECIST;
- Sorafenib;
- Hepatic arterial infusion chemotherapy;
7.Hepatocellular Carcinoma Intermediate Stage Subclassification Systems: One, None, and One Hundred Thousand

机译：肝细胞癌中间阶段级分类系统：一，无，和十万
- 作者：Giannini EdoardoG.;Bodini Giorgia;Furnari Manuele;Marabotto Elisa
- 期刊名称：《Liver cancer.》 | 2019年第6期
8.A New Treatment Option for Intermediate-Stage Hepatocellular Carcinoma with High Tumor Burden: Initial Lenvatinib Therapy with Subsequent Selective TACE

机译：具有高肿瘤负荷的中期肝细胞癌的新治疗选择：初始Lenvatinib治疗随后的选择性TACE
- 作者：Kudo Masatoshi
- 期刊名称：《Liver cancer.》 | 2019年第5期
9.Patients with Barcelona Clinic Liver Cancer Stages B and C Hepatocellular Carcinoma: Time for a Subclassification

机译：巴塞罗那临床肝癌患者B和C肝细胞癌：子分类时间
- 作者：Golfieri Rita;Bargellini Irene;Spreafico Carlo;Trevisani Franco
- 期刊名称：《Liver cancer.》 | 2019年第2期
10.Intracranial Bleeding during Treatment with Sorafenib for Hepatocellular Carcinoma

机译：颅内出血治疗嗜胞胎肝癌治疗
- 作者：Hata Taigo;Uwagawa Tadashi;Yanaga Katsuhiko
- 期刊名称：《Liver cancer.》 | 2019年第6期
11.Increased Expression of Programmed Death-Ligand 1 in Infiltrating Immune Cells in Hepatocellular Carcinoma Tissues after Sorafenib Treatment

机译：在索拉非尼治疗后，在肝细胞癌组织中浸润免疫细胞的编程死亡 - 配体1的表达增加
- 作者：Lu Li-Chun;Lee Yi-Hsuan;Chang Chun-Jung;Shun Chia-Tung;Fang Chih-Yeu;Shao Yu-Yun;Liu Tsung-Hao;Cheng Ann-Lii;Hsu Chih-Hung
- 期刊名称：《Liver cancer.》 | 2019年第2期
- Hepatocellular carcinoma;
- Macrophage;
- Programmed death-ligand 1;
- Sorafenib;
- Tumor microenvironment;
12.Hepatocellular Carcinoma with Irregular Rim-Like Arterial Phase Hyperenhancement: More Aggressive Pathologic Features

机译：肝细胞癌具有不规则的边缘动脉期Hyperenhancement：更具侵略性的病理特征
- 作者：Hyungjin Rhee;Chansik An;Hye-Young Kim;Jeong?Eun Yoo;Young?Nyun Park;Myeong-Jin Kim
- 期刊名称：《Liver cancer.》 | 2019年第1期
- Fibrous stroma;
- Hypoxia;
- Stemness;
- Macrotrabecular pattern;
- Microvascular density;
13.Multibipolar Radiofrequency Ablation for the Treatment of Mass-Forming and Infiltrative Hepatocellular Carcinomas > 5 cm: Long-Term Results

机译：用于治疗成分和渗透肝细胞癌的多宝射频消融> 5cm：长期结果
- 作者：NKontchou Gisele;Nault Jean-Charles;Sutter Olivier;Bourcier Valerie;Coderc Emmanuelle;Grando Veronique;Nahon Pierre;Ganne-Carrie Nathalie;Diallo Abou;Sellier Nicolas;Seror Olivier
- 期刊名称：《Liver cancer.》 | 2019年第3期
- Hepatocellular carcinoma;
- Large tumor;
- Multibipolar technology;
- No touch technique;
- Radiofrequency ablation;
14.Scientific Rationale for Combination Immunotherapy of Hepatocellular Carcinoma with Anti-PD-1/PD-L1 and Anti-CTLA-4 Antibodies

机译：抗PD-1 / PD-L1和抗CTLA-4抗体的肝细胞癌组合免疫疗法的科学理论
- 作者：Kudo Masatoshi
- 期刊名称：《Liver cancer.》 | 2019年第6期
15.Ramucirumab as Second-Line Systemic Therapy in Hepatocellular Carcinoma

机译：Ramucirumab作为肝细胞癌中的二线全身治疗
- 作者：Kudo Masatoshi
- 期刊名称：《Liver cancer.》 | 2018年第4期
16.Body Composition Is an Independent Predictor of Outcome in Patients with Hepatocellular Carcinoma Treated with Sorafenib

机译：身体组成是用索拉非尼治疗的肝细胞癌患者的患者的独立预测因素
- 作者：Labeur Tim A.;van Vugt Jeroen L. A.;Ten Cate David W. G.;Takkenberg R. Bart;IJzermans Jan N. M.;Koerkamp Bas Groot;de Man Robert A.;van Delden Otto M.;Eskens Ferry A. L. M.;Klumpen Heinz-Josef
- 期刊名称：《Liver cancer.》 | 2019年第4期
- Hepatocellular carcinoma;
- Sorafenib;
- Body composition;
- Skeletal muscle mass;
- Total adipose tissue area;
- Prognosis;
17.APPLE 2019

机译：苹果公司2019.
- 期刊名称：《Liver cancer.》 | 2019年第1期
18.Sorafenib: Experience and Better Management of Side Effects Improve Overall Survival in Hepatocellular Carcinoma Patients: A Real-Life Retrospective Analysis

机译：索拉菲尼布：体验和更好的副作用管理改善肝细胞癌患者的整体生存：真实的回顾性分析
- 作者：Raoul Jean-Luc;Adhoute Xavier;Penaranda Guillaume;Perrier Herve;Castellani Paul;Oules Valerie;Bourliere Marc
- 期刊名称：《Liver cancer.》 | 2019年第6期
- Sorafenib;
- Hepatocellular carcinoma;
- Learning curve;
- Prognosis;
- Adverse events;
19.The APPLE Association President's Message

机译：苹果协会总裁的信息
- 期刊名称：《Liver cancer.》 | 2019年第1期
20.Multidisciplinary Taiwan Consensus Recommendations for the Use of DEBDOX-TACE in Hepatocellular Carcinoma Treatment

机译：多学科台湾共识建议，用于在肝细胞癌治疗中使用脱霉素 - TACE
- 作者：Chang Pi-Yi;Huang Chun-Chieh;Hung Chao-Hung;Yu Chih-Yung;Wu Ding-Kwo;Hwang Jen-I;Liang Po-Chin;Wu Reng-Hong;Tsai Wei-Lun;Lin Yih-Jyh;Liu Yi-Sheng;Liang Huei-Lung;Lee Rheun-Chuan;Chen Chien-Hung
- 期刊名称：《Liver cancer.》 | 2018年第4期
- Chemoembolization;
- DEBDOX;
- Doxorubicin;
- Drug-eluting bead;
- Hepatocellular carcinoma;
21.Association of Platelet Count and Mean Platelet Volume with Overall Survival in Patients with Cirrhosis and Unresectable Hepatocellular Carcinoma

机译：血小板计数与平均血小板体积与肝硬化患者整体存活的血小板数量和不可切除的肝细胞癌
- 作者：Scheiner Bernhard;Kirstein Martha;Popp Sabine;Hucke Florian;Bota Simona;Rohr-Udilova Nataliya;Reiberger Thomas;Mueller Christian;Trauner Michael;Peck-Radosavljevic Markus;Vogel Arndt;Sieghart Wolfgang;Pinter Matthias
- 期刊名称：《Liver cancer.》 | 2019年第3期
- Thrombocytopenia;
- Mean platelet volume;
- Hepatocellular carcinoma;
- Cirrhosis;
- Survival;
22.ALBI Score as a Novel Tool in Staging and Treatment Planning for Hepatocellular Carcinoma: Is It Sufficient?

机译：Albi评分作为肝细胞癌分期和治疗计划的新型工具：是否足够？
- 作者：Huo Teh-Ia;Liu Po-Hong;Hsu Chia-Yang
- 期刊名称：《Liver cancer.》 | 2017年第4期
23.Risk of de novo Hepatocellular Carcinoma after HCV Treatment with Direct-Acting Antivirals

机译：直接作用抗病毒药后HCV治疗后De Novo肝细胞癌的风险
- 作者：Fabian Finkelmeier;Georg Dultz;Kai-Henrik Peiffer;Bernd Kronenberger;Franziska Krauss;Stefan Zeuzem;Christoph Sarrazin;Johannes Vermehren;Oliver Waidmann
- 期刊名称：《Liver cancer.》 | 2018年第2期
- Hepatitis C;
- Hepatocellular carcinoma;
- Direct-acting antivirals;
24.Anatomical Study of the Caudate Lobe with Special Reference to Portal Venous and Biliary Branches Using Corrosion Liver Casts and Clinical Application

机译：耐腐蚀肝铸造及临床应用特殊参考门静脉和胆汁分支的尾叶的解剖学研究
- 作者：Masamitsu Kumon
- 期刊名称：《Liver cancer.》 | 2017年第2期
- Corrosion liver casts;
- Liver segments;
- Anatomy of the liver;
- Liver surgery;
- Biliary surgery;
25.Albumin-Bilirubin Grade and Hepatocellular Carcinoma Treatment Algorithm

机译：白蛋白 - 胆红素级和肝细胞癌处理算法
- 作者：M. Kudo
- 期刊名称：《Liver cancer.》 | 2017年第3期
26.Short-Term Outcomes following Hepatectomy in Elderly Patients with Hepatocellular Carcinoma: An Analysis of 10,805 Septuagenarians and 2,381 Octo- and Nonagenarians in Japan

机译：肝切除术患者肝切除术后的短期成果：分析了日本10,805株式会膜和2,381名八十八大人
- 作者：Okinaga Hiroko;Yasunaga Hideo;Hasegawa Kiyoshi;Fushimi Kiyohide;Kokudo Norihiro
- 期刊名称：《Liver cancer.》 | 2018年第1期
- Hepatocellular carcinoma;
- Octo-/nonagenarians;
- Super elderly;
- Surgery;
27.Hepatocellular Carcinoma with Macrovascular Invasion: Defining the Optimal Treatment Strategy

机译：肝细胞癌具有大血管侵袭：定义最佳治疗策略
- 作者：Costentin Charlotte E.;Ferrone Cristina R.;Arellano Ronald S.;Ganguli Suvranu;Hong Theodore S.;Zhu Andrew X.
- 期刊名称：《Liver cancer.》 | 2017年第4期
- Hepatocellular carcinoma;
- Macrovascular invasion;
- Sorafenib alternatives;
28.Vinyl Institute Comments on Cicalese et al.: 'An Ecological Study of the Association between Air Pollution and Hepatocellular Carcinoma Incidence in Texas'

机译：乙烯基学院评论科克斯等人：“德克萨斯州空气污染与肝细胞癌发生率关联的生态研究”
- 作者：Krock Richard
- 期刊名称：《Liver cancer.》 | 2018年第3期
29.Hong Kong Consensus Statements for the Management of Unresectable Hepatocellular Carcinoma

机译：香港不可切除的肝细胞癌管理的共识陈述
- 作者：Cheung Tan-To;Kwok Philip Chong-Hei;Chan Stephen;Cheung Chin-Cheung;Lee Ann-Shing;Lee Victor;Cheng Hoi-Ching;Nam-Hung Chia;Chong Charing C. N.;Lai Tak-Wing;Law Ada L. Y.;Luk Mai-Yee;Tong Chi Chung;Yau Thomas C. C.
- 期刊名称：《Liver cancer.》 | 2018年第1期
- Consensus;
- Hepatocellular carcinoma;
- Unresectable HCC;
- Hong Kong;
30.Albumin-Bilirubin (ALBI) Grade as Part of the Evidence-Based Clinical Practice Guideline for HCC of the Japan Society of Hepatology: A Comparison with the Liver Damage and Child-Pugh Classifications

机译：白蛋白 - 胆红素（Albi）等级作为日本肝脏学会HCC的基于证据的临床实践指南的一部分：与肝脏损伤和儿童 - PUGH分类进行比较
- 作者：Atsushi Hiraoka;Takashi Kumada;Masatoshi Kudo;Masashi Hirooka;Kunihiko Tsuji;Ei Itobayashi;Kazuya Kariyama;Toru Ishikawa;Kazuto Tajiri;Hironori Och;Toshifumi Tada;Hidenori Toyoda;Kazuhiro Nouso;Kouji Joko;Hideki Kawasaki;Yoichi Hiasa;Kojiro Michitaka;on behalf of the Real-Life Practice Experts for HCC (RELPEC);Study Group HCC 48 Group (hepatocellular carcinoma experts from 48 clinics)
- 期刊名称：《Liver cancer.》 | 2017年第3期
- ALBI grade;
- Indocyanine green;
- Liver damage;
- Child-Pugh;
- Hepatocellular carcinoma;
31.Current Status on Cholangiocarcinoma and Gallbladder Cancer

机译：胆管癌和胆囊癌的现状
- 作者：Tomoki Ebata;Giorgio Ercolani;Domenico Alvaro;Dario Ribero;Luca Di Tommaso;Juan W. Valle
- 期刊名称：《Liver cancer.》 | 2017年第1期
- Biliary tract cancer;
- Cholangiocarcinoma;
- Gallbladder cancer;
32.The Overall Survival of Patients with Hepatocellular Carcinoma Correlates with the Newly Defined Time to Progression after Transarterial Chemoembolization

机译：肝细胞癌患者的整体存活与横冲化疗栓塞后的新定义的进展时间相关
- 作者：Tadaaki Arizumi;Kazuomi Ueshima;Mina Iwanishi;Tomohiro Minami;Hirokazu Chishina;Masashi Kono;Masahiro Takita;Norihisa Yada;Satoru Hagiwara;Yasunori Minami;Hiroshi Ida;Yoriaki Komeda;Mamoru Takenaka;Toshiharu Sakurai;Tomohiro Watanabe;Naoshi Nishida;Masatoshi Kudo
- 期刊名称：《Liver cancer.》 | 2017年第3期
33.How to Differentiate Borderline Hepatic Nodules in Hepatocarcinogenesis: Emphasis on Imaging Diagnosis

机译：如何区分肝癌发生中的边缘肝结节：重点是成像诊断
- 作者：Hyun Jeong Park;Byung Ihn Choi;Eun Sun Lee;Sung Bin Park;Jong Beum Lee
- 期刊名称：《Liver cancer.》 | 2017年第3期
- Hepatocarcinogenesis;
- Dysplastic nodule;
- Hepatocellular carcinoma;
- Imaging diagnosis;
- Borderline nodule;
34.Molecular Targeted Agents for Hepatocellular Carcinoma: Current Status and Future Perspectives

机译：用于肝细胞癌的分子靶向剂：现状和未来的观点
- 作者：M. Kudo
- 期刊名称：《Liver cancer.》 | 2017年第2期
35.ALBI Score as a Novel Tool in Staging and Treatment Planning for Hepatocellular Carcinoma: Advantage of ALBI Grade for Universal Assessment of Hepatic Function

机译：Albi评分作为肝细胞癌的分期和治疗计划中的一种新型工具：Albi级肝功能评估的优势
- 作者：Hiraoka Atsushi;Michitaka Kojiro;Kumada Takashi;Kudo Masashi
- 期刊名称：《Liver cancer.》 | 2017年第4期

客服邮箱：kefu@zhangqiaokeyan.com

客服微信
服务号